VRDN Viridian Therapeutics, Inc.
$31.44
Viridian Therapeutics, Inc. (VRDN) Earnings News
Earnings press releases, previews and reviews for Viridian Therapeutics, Inc. (VRDN), newest first. Our most recent is review: Viridian's Lumvoa Launch Crushes Revenue Expectations, but Thin Disclosure Leaves Durability Questions Open.
Wednesday
November 4, 2026
10:13 AM ET
Viridian's Lumvoa Launch Crushes Revenue Expectations, but Thin Disclosure Leaves Durability Questions Open
Earnings Whispers · Review
Wednesday
November 4, 2026
7:01 AM ET
Viridian Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Recent Business Progress
Tuesday
October 27, 2026
3:08 PM ET
Viridian's Q3 Loss Should Hold Near $1 a Share; Cash and VRDN-001 Progress Matter More
Earnings Whispers · Preview
Tuesday
October 20, 2026
4:00 PM ET
Viridian Therapeutics to Report Third Quarter 2026 Financial Results on November 4, 2026
Thursday
August 6, 2026
7:01 AM ET
Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results